Promega Corporation, a manufacturer of innovative solutions for molecular diagnostics, clinical research, life sciences, and human identification will host its second session in A Microsatellite Instability (MSI) Series, on October 26, 2021. MSI has rapidly advanced as an important pan tumor biomarker associated with response to immune checkpoint inhibitors and the drive towards universal tumor testing.
In Session 3, you will have the opportunity to learn more about MSI, and obtain CE Credits, from speakers who will present (with live Q&A) on the following topics:
In addition to the presentations, you will have the opportunity to:
To learn more about the event and register, please visit: https://www.labroots.com/ms/virtual-event/msi-series.
With a portfolio of more than 4,000 products, Promega has a breadth of solutions spanning the clinical laboratory’s workflow and cGMP OEM solutions for diagnostic manufacturers. Promega is a trusted partner, with more than 40 years of manufacturing experience, to supply the robust and reliable solutions you need for your molecular assays.
LabRoots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Not registered yet as a LabRoots user? Click here to sign up for free.